Replimune (REPL) Other Working Capital Changes (2017 - 2025)
Replimune's (REPL) quarterly Other Working Capital Changes came in at $268000.0 in Q4 2025, up 6.77% year-on-year from $251000.0 in Q4 2024, and up 263.41% quarter-over-quarter from -$164000.0 in Q3 2025.
Replimune (REPL) Other Working Capital Changes (2017 - 2025) Analysis & Trends
Replimune has disclosed Other Working Capital Changes across 9 years of filings, most recently posting $268000.0 for Q4 2025.
- Other Working Capital Changes for Q4 2025 came in at $268000.0, up 6.77% year-over-year; the trailing twelve-month figure through Dec 2025 was $124000.0 (down 80.86% YoY), and the FY2025 annual result was $155000.0, down 50.64% from the prior year.
- Other Working Capital Changes came in at $268000.0 for Q4 2025 at Replimune, up from -$164000.0 in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $2.4 million in Q3 2023 to a low of -$2.7 million in Q4 2023.
- The 5-year median for Other Working Capital Changes is -$106000.0 (2021), against an average of $141157.9.
- Peak annual rise in Other Working Capital Changes reached 1606.92% in 2023, while the deepest fall reached 1783.02% in 2023.
- Replimune's Other Working Capital Changes stood at $1.1 million in 2021, then slumped by 86.16% to $159000.0 in 2022, then tumbled by 1783.02% to -$2.7 million in 2023, then jumped by 109.38% to $251000.0 in 2024, then gained by 6.77% to $268000.0 in 2025.
- The last three Other Working Capital Changes figures came in at $268000.0 (Q4 2025), -$164000.0 (Q3 2025), and -$234000.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - |
| 10 | Replimune | 780.01 Mn | 510.88 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 268,000.00 |
| Dec 31, 2025 | 268,000.00 |
| Sep 30, 2025 | -164,000.00 |
| Sep 30, 2025 | -164,000.00 |
| Jun 30, 2025 | -234,000.00 |
| Jun 30, 2025 | -234,000.00 |
| Mar 31, 2025 | 254,000.00 |
| Mar 31, 2025 | 254,000.00 |
| Dec 31, 2024 | 251,000.00 |
| Dec 31, 2024 | 251,000.00 |
| Sep 30, 2024 | -179,000.00 |
| Sep 30, 2024 | -179,000.00 |
| Jun 30, 2024 | -171,000.00 |
| Jun 30, 2024 | -171,000.00 |
| Mar 31, 2024 | 747,000.00 |
| Mar 31, 2024 | 747,000.00 |
| Dec 31, 2023 | -2.68 Mn |
| Dec 31, 2023 | -2.68 Mn |
| Sep 30, 2023 | 2.40 Mn |
| Sep 30, 2023 | 2.40 Mn |